EFFECTIVENESS AND SAFETY OF PIMECROLIMUS IN TREATMENT OF ATOPIC DERMATITIS IN CHILDREN AND ADOLESCENTS
The results of treatment of 57 patients with atopic dermatitis (ATD) in age 7–18 years old with elidel cream are described. Cream was drifted on facial skin 2 times daily. Apparent effect was marked on 7–14 day. There was no any case of serious adverse events. Thus, taking to account safety and effe...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2008-12-01
|
| Series: | Вопросы современной педиатрии |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/1495 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The results of treatment of 57 patients with atopic dermatitis (ATD) in age 7–18 years old with elidel cream are described. Cream was drifted on facial skin 2 times daily. Apparent effect was marked on 7–14 day. There was no any case of serious adverse events. Thus, taking to account safety and effectiveness profile, pimecrolimus can be used as a medication of first line of therapy in treatment of ATD, while lesion is located on sensitive sectors of skin.Key words: children, atopic dermatitis, pimecrolimus. |
|---|---|
| ISSN: | 1682-5527 1682-5535 |